Renin-angiotensin-aldosterone system inhibitors and COVID-19 infection or hospitalization: a cohort study.
CONCLUSIONS: These findings support current recommendations that individuals on these medications continue their use.
PMID: 33048112 [PubMed - as supplied by publisher]
Source: American Journal of Hypertension - Category: Cardiology Authors: Dublin S, Walker R, Floyd JS, Shortreed SM, Fuller S, Albertson-Junkans L, Harrington LB, Greenwood-Hickman MA, Green BB, Psaty BM Tags: Am J Hypertens Source Type: research
More News: Cardiology | COVID-19 | Eating Disorders & Weight Management | Hypertension | Laboratory Medicine | Obesity | Study